Public Perceptions On the Technological Frontier David Rejeski Director, Foresight and Governance Program Woodrow Wilson International Center for Scholars Opportunities and Challenges in the Emerging Field of Synthetic Biology National Academies, Royal Society, OECD Washington, DC July 10, 2009
Public Perceptions On the Technological Frontier David Rejeski Director, Foresight and Governance Program Woodrow Wilson International Center for Scholars Opportunities and Challenges in the Emerging Field of Synthetic Biology National Academies, Royal Society, OECD Washington, DC July 10, 2009. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Public Perceptions
On the Technological Frontier
David RejeskiDirector, Foresight and Governance Program
Woodrow Wilson International Center for Scholars
Opportunities and Challenges in the Emerging Field of Synthetic Biology
National Academies, Royal Society, OECDWashington, DC
July 10, 2009
1. Review some of the initial research findings on public perception of synthetic biology (including comparisons between US-UK research and earlier work on nanotechnology).2. Share some observations about the social context and challenges as synthetic biology moves forward.
Three Goals
3. End with some near-term needs.
U.S. Public Perceptions of Synthetic Biology
■ Quantitative Study:
The first representative national phone survey of 1,003 US adults nationwide conducted on August 20-25, 2008by Peter D. Hart Research Associatesat the request of the Wilson Center
■ Qualitative Study:
Two focus groups sessions conducted in Baltimore (Maryland) on August 6, 2008 among (18-65) adults – one focus group among women, one among men – from a relatively large diversity of social, religious background
U.S. Public Awareness of Synthetic Biology
■ In both focus groups and the phone survey, 70% of participants had heard nothing at all about synthetic biology
How much have you heard about synthetic biology?
22%
2%
67%
9%
Heard nothing
at all
Not sure
Heard a lot (2%)
or some (7%)
Heard just a little
Nanotechnology Awareness, 2008
Synthetic What?
U.S. Public Perceptions of Synthetic Biology
■ Despite their lack of knowledge, 70% of the phone survey participants gave a personal description of synthetic biology and 66% ventured an opinion on the risk-benefit tradeoff.
Will potential benefits of synthetic biology outweigh its potential risks?
21%
16%
34%
29%
Not sure
Benefits will outweigh risks
Benefits & risks will be about equal
Risks will outweigh benefits
66%
Risks versus Benefits
With information
U.S. Public Perceptions of Synthetic Biology
What would you say are some of the major benefits of synthetic
biology? Which applications do you think is most promising?
Potential Applications of Synthetic
Biology
Focus Group 1(Female Participants)
Focus Group 2 (Male Participants)
Biofuels 4 4Drugs for Treating
Diseases 1 3New Ways to Treat
Cancer 3 1Sensing Harmful
Contaminants 0 0Cleaning Up the
Environment 3 1
Overall Rankings of Potential Applications of Synthetic Biology(Values Reflect Number of Participants in Each Group Who Valued the Given Application
the Most)
What Applications Matter Most?
Comparison of U.S. and UK Public Perceptions Synbio Applications Matter! Similar Enthusiasm for biofuels
US“Sounds great, good deal, biofuels, I love that.”
“I really like the idea of generating, constructing a bacteria to generate hydrogen.”
“I like, about the biofuels, how they said it produces cleaner fuels…That could be good as far as going greener for the environment.”
“That [bacteria generating biofuels] would be fantastic.”
UK“We picked biofuels, basically because we felt it would have the biggest world impact of the four, because of the global concern about fuels in general and the CO2 emissions that it would actually save.”
“It will have the biggest impact on individual users. I know the anti-malarial drug is fantastic but it only will hit three or four million people, whereas there’s millions and millions of car drivers.”
U.S. Public Perceptions of Synthetic Biology
Whose job should it be to regulate or manage the risks associated with synthetic biology?
Best Approach to Managing the Risks Associated with Synthetic Biology
(Values Reflect Numbers of Participants in Each Group in Favor of Described Approach)
Best Approach to Manage the Risks Associated with
Synthetic Biology
Focus Group 1 Female Participants
Focus Group 2Male Participants
All Participants
Require the Federal Government to Regulate Synthetic Biology 4 4 8
Allow the Scientific Community and Others Involved in
Advancements to Regulate Synthetic Biology
6 0 6
Ban the Further Development and Use of Synthetic Biology 1 4 5
Allow Companies and Private Funders Investing in Research and Development to Regulate
Synthetic Biology
0 1 1
Oversight
Comparison of U.S. and UK Public Perceptions
What about Regulation?Similar views on the best way to manage synbio’s governance No ban but government regulation with checks and balances and independent science involvement.
US“I feel [federal government] it’s the best approach because I don’t agree with banning it [the technology].”
“I think they [scientists] should be part of the team because they bring so much knowledge and understanding.”
UK“We didn’t think that any needed to be stopped, but the huge benefits also carry great risks […]. So we’d definitely want to have very tight safety and control regulations.”
“We’re not scientists. It’s really what it’s trying to do, the benefits and how it’s trying to solve problems around the world that’s of interest to me, rather than the nitty gritty of the science.”
Comparison of U.S. and UK Public Perceptions
Recommendations?Similar recommendations to scientists and policy-makers Openness and transparency increase public trust.
US“I think it’s exciting. I think it has a lot of potential, and we should continue to pursue it. But in doing it, all of these concerns need to be considered. And then the developer’s reaction to them and how they’re going to deal with it, whether it’s communication or regulation, needs to be clearly displayed. You got to have some support from everybody, and I don’t hear it here. There’s a lot of caution.”
UK “Open dialogue, highlighting the benefits and also highlighting the risks”
“We felt that a lot of people close down, again because of the bad press about GM crops, and people need to think more about the positives rather than the negatives. It’s just a case of listening and understanding.”
Public Expectations for Oversight
When asked “How can public confidence in nanotechnologies be improved?” people converged around three recommendations:
1. Greater transparency and disclosure2. Pre-market testing3. Third-party testing and research
(For Nanotechnology) There was little public support for:
- A moratorium on research and development
- Self-regulation
Results from 30 hours of focus groups conducted by the Project on Emerging Nanotechnologies between 2005 and 2007.
The name “synthetic biology” can be a liability.
Definitions?
“When the name is bad, things tend to get worse. When the name is good, things tend to get better.”
Al Ries and Jack Trout Positioning: The Battle for Your Mind, 1981
No communication or public engagement strategy (by the scientific community, industry, or government).
Some Challenges
The “playing God” issue.
High Potential for Risk Amplification
The global H1N1 pandemic raises public anxiety of biological issues and threats.
Good science journalists are becoming an extinct species = greater potential for ill-informed, sensationalistic coverage.
The American public has experienced repeated failures of government regulation and oversight spanning food, drugs, consumer products, and finance = trust gap.
U.S. NGOs are engaged early on synbio (could push back on the science and its applications).
From: “Public Awareness of Nanotechnology: What do Americans know? Who do they trust?” Project on Emerging Nanotechnologies, 9/2007, www.nanotechproject.org
52%44%
41%57%
40%58%
37%59%
Great deal/fair amount of confidenceJust some/very little confidence
Confidence in Each to Maximize Benefits & Minimize Risks of Scientific/Technological Advancements
FDA
EPA
USDA
Businesses/
companies
The Trust Gap
New Opponents?
Inversion of the Leiserowitz effect (found by Kahan et al)1 Anthony Leiserowitz labeled as “environmental risk naysayers”
a segment of U.S. society whose members are disproportionately white and male, politically conservative, and highly religious.2
1. Kahan, D. et al “Risk and Culture: Is Synthetic Biology Different?” Cultural Cognition Working Paper #29.2. Leiserowitz, A.A. American risk perceptions: Is climate change dangerous? Risk Anal. 25, 1433-1442 (2005)
More concerned
Less concerned
Nuclear PowerGlobal WarmingMad Cow
Synthetic Biology
Kahan, D. et al (2007). “Affect, Values, and Nanotechnology Risk Perceptions: An Experimental Investigation,” Cultural Cognition Project Working Paper #22.
Benefits > Risks
Risks > Benefits
Polarization?
Messengers for Synthetic Biology?
“[People] will almost certainly decide whom to trust in exactly the way they normally do, namely, by assessing who it is in the debate at hand who seems most like themselves.”
Kahan, D. et al (2008): Biased Assimilation, Polarization, and Cultural Credibility: An Experimental Study of Nanotechnology Risk Perceptions
Which Messengers?
?
“Scientists, policymakers, and others interested in promoting enlightened public evaluation of the best available information on … risks should take affirmative steps to create a deliberative climate that neutralizes biased assimilation and polarization.”
Based on research, need a public communications and engagement strategy; one that scales.
Need more applied research on public attitudes and perceptions, including international comparisons (and we need it soon).
Near-Term Needs
Risk research and analyses of regulatory adequacy.
More international cooperation.
Where is the risk research in U.S. funding?
“We tell ourselves stories to live.”
Joan Didion
References:
Hart Research Associates (2008), Awareness of and attitudes toward nanotechnology and synthetic biology. Available at: http://www.synbioproject.org/process/assets/files/6019/hart_final_re8706b.pdf
Kahan DM et al. (2009), Risk and Culture: Is Synthetic Biology Different?, in Harvard Law School Program on Risk Regulation Research Paper No. 09-2. Available at SSRN: http://ssrn.com/abstract=1347165
Pauwels E, Ifrim I (2008), Trends in American and European press coverage of synthetic biology: Tracking the last five years of coverage, in Synbio 1 (Synthetic Biology Project, 2008). Available at: http://www.synbioproject.org/process/assets/files/5999/synbio1final.pdf
Scheufele DA et al. (2008), Religious beliefs and public attitudes towards nanotechnology in Europe and the United States. Nature Nanotech. 361, 1-4.
Methodology:
Pauwels E, Ifrim I (2008), Trends in American and European press coverage of synthetic biology: Tracking the last five years of coverage, in Synbio 1 (Synthetic Biology Project, 2008), p. 25-26.
Hart Research Associates (2008), Awareness of and attitudes toward nanotechnology and synthetic biology, p. 1-2.